ArticleFrontiers in pharmacology2025
Case Report: A case of Felty's syndrome with initial presentation of pleural effusion and subsequent
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pleural effusion is a common disease in respiratory medicine, and rheumatoid arthritis (RA) is one of the causes of pleural effusion. Felty's syndrome is a special manifestation of RA. We report a case of Felty's syndrome with pleural effusion as the initial symptom and the subsequent diagnosis and treatment of the patient's secondary pyothorax. Case presentation: We report the case of a 78-year-old male who was admitted to the hospital after more than 1 year of discovered pleural effusion. After consultation with the Department of Rheumatology and Immunology, and considering the patient's symptoms of joint deformity and swelling pain, combined with decreased white blood cells, decreased platelets, and splenomegaly, the patient was diagnosed with RA Felty's syndrome. The patient was treated with iguratimod and methylprednisolone. Three months later, the patient was diagnosed as Conclusion: Felty's syndrome is a rare manifestation of RA. Pleural effusion may be the initial manifestation of RA, and secondary infections are prone to occur during the treatment of RA and Felty's syndrome. The combination of sensitive antibiotics and medical thoracoscopy can effectively treat secondary pyothorax.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.